(Q45814438)

16 December 2017

title

A Controlled Family Study of Live, Attenuated Rubella-Virus Vaccine (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

18 March 2023

1 reference

1 reference

Lefkowitz LB Jr

1

1 reference

16 December 2017

Rafajko RR

2

1 reference

16 December 2017

Federspiel CF

3

1 reference

16 December 2017

Quinn RW

4

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 1970

1 reference

16 December 2017

30 July 1970

1 reference

National Center for Biotechnology Information

PubMed ID

4912790

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4912790

full work available at URL

18 March 2023

number of pages

4

1 reference

based on heuristic

inferred from page(s)

http://www.nejm.org/doi/pdf/10.1056/NEJM197007302830504

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

The New England Journal of Medicine

18 March 2023

published in

1 reference

16 December 2017

volume

283

1 reference

16 December 2017

issue

5

1 reference

16 December 2017

page(s)

229-232

1 reference

16 December 2017

Attenuated rubella virus. I. Development and laboratory characterization

cites work

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Rubella-virus hemagglutination-inhibition test

18 March 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Rubella Complement Fixing Antigen Prepared by Alkaline Extraction Of Virus Grown in Suspension Culture of BHK-21 Cells

18 March 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

RUBELLA ANTIBODIES IN HUMAN SERUM: DETECTION BY THE INDIRECT FLUORESCENT ANTIBODY TECHNIC.

18 March 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial

18 March 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella

18 March 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Attenuated rubella viruses. Laboratory and clinical characteristics

18 March 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Attenuated rubella virus vaccine in women. Clinical trials during the postpartum period

18 March 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.

18 March 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine

18 March 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM197007302830504

18 March 2023

Identifiers

1 reference

16 December 2017

PubMed ID

4912790

1 reference

16 December 2017